Andrew R. de Guttadauro

Präsident bei Oncolytics Biotech (U.S.), Inc.

Vermögen: 11 037 $ am 31.05.2024

57 Jahre

4 Beziehungen

Health Technology

Consumer Services

Health Services

Ursprung des Netzwerks ersten Grades von Andrew R. de Guttadauro

Einheit	Art der Einheit	Industrie
Oncolytics Biotech (U.S.), Inc. Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Oncolytics Biotech (US), Inc. is based in Half Moon Bay, CA. Part of Oncolytics Biotech, Inc., Oncolytics Biotech (US), Inc. is a company that manufactures pharmaceutical products. 2	Subsidiary	Pharmaceuticals: Major	2
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. 2	Extinct	Pharmaceuticals: Major	2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Andrew R. de Guttadauro

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
MERCK & CO., INC.	Pharmaceuticals: Major	Ronald B. Moss	General Counsel
ID Biomedical Corp. ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.	Medical Specialties	Richard Kenney	Chief Tech/Sci/R&D Officer
Orchestra Therapeutics, Inc. Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA.	Financial Conglomerates	Ronald B. Moss	Chief Executive Officer
MARKER THERAPEUTICS, INC.	Biotechnology	Richard Kenney	Chief Tech/Sci/R&D Officer
ONCOLYTICS BIOTECH INC.	Biotechnology	Mary Ann Dillahunty Kirk Look	Corporate Officer/Principal Director of Finance/CFO
Biosortia Pharmaceuticals, Inc. Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH.	Biotechnology	Ronald B. Moss	Director/Board Member
Michigan State University	College/University	Mary Ann Dillahunty	Undergraduate Degree
George Washington University	College/University	Mary Ann Dillahunty Richard Kenney	Masters Business Admin Undergraduate Degree
Ernst & Young Chile Ltda. Ernst & Young Chile Ltda. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Chile Ltda. The company is based in Santiago, Chile. is a Chilean company that provides accounting services.	Miscellaneous Commercial Services	Kirk Look	Corporate Officer/Principal
Stony Brook University	College/University	Ronald B. Moss	Undergraduate Degree
University of Calgary	College/University	Kirk Look	Undergraduate Degree
IOMAI CORPORATION	Biotechnology	Richard Kenney	Chief Tech/Sci/R&D Officer
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	General Government	Ronald B. Moss	Corporate Officer/Principal
Janssen Vaccines & Prevention BV Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.	Pharmaceuticals: Major	Richard Kenney	Chief Tech/Sci/R&D Officer
US Food & Drug Administration US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.	General Government	Richard Kenney	Corporate Officer/Principal
Ernst & Young LLP (Canada) Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada.	Miscellaneous Commercial Services	Kirk Look	Corporate Officer/Principal
Rosalind Franklin University of Medicine & Science	College/University	Ronald B. Moss	Doctorate Degree
American Federation for Medical Research		Richard Kenney	Corporate Officer/Principal
American Society of Tropical Medicine & Hygiene American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services The American Society of Tropical Medicine & Hygiene is a health community dedicated to reducing the worldwide burden of tropical infectious diseases and improving health. The non-profit company is based in Northbrook, IL. Members have access to research on the latest diseases and treatments, a standing within their community, learning about clinical cases and field work, and finding collaborators.	Miscellaneous Commercial Services	Richard Kenney	Corporate Officer/Principal
IMMUNE DESIGN CORP	Pharmaceuticals: Major	Richard Kenney	Chief Tech/Sci/R&D Officer
Telos Pharmaceuticals LLC		Ronald B. Moss	Chief Tech/Sci/R&D Officer
Immunization Products Ltd.		Ronald B. Moss	Corporate Officer/Principal
DMK PHARMACEUTICALS CORPORATION	Pharmaceuticals: Major	Ronald B. Moss	Chief Tech/Sci/R&D Officer
Harvard Medical School	College/University	Richard Kenney	Doctorate Degree
Stanford Law School	College/University	Mary Ann Dillahunty	Graduate Degree
Seton Hall University School of Law	College/University	Kirk Look	Graduate Degree
Ansun Biopharma, Inc. Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA.	Pharmaceuticals: Major	Ronald B. Moss	Chief Executive Officer
X-Vax Technology, Inc. X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY.	Biotechnology	Richard Kenney	Corporate Officer/Principal
ClinReg Biologics LLC		Richard Kenney	President
SONNET BIOTHERAPEUTICS HOLDINGS, INC.	Biotechnology	Richard Kenney	Chief Tech/Sci/R&D Officer
Chicago Medical School	College/University	Ronald B. Moss	Doctorate Degree